On the other hand, some studies have reported the overexpression of HER-2/neu suggesting its use as a marker to differentiate healthy from cancer tissues (Cavalot et al., 2007; Fonget al., 2008; Lebeau et al., 2001). This evidence concerns the gene ERBB2 and cancer.